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Fully immunized child: coverage, timing
and sequencing of routine immunization in
an urban poor settlement in Nairobi, Kenya
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and Elizabeth Echoka1,3
Abstract
Background: More efforts have been put in place to increase full immunization coverage rates in the last decade.
Little is known about the levels and consequences of delaying or vaccinating children in different schedules.
Vaccine effectiveness depends on the timing of its administration, and it is not optimal if given early, delayed or
not given as recommended. Evidence of non-specific effects of vaccines is well documented and could be linked
to timing and sequencing of immunization. This paper documents the levels of coverage, timing and sequencing
of routine childhood vaccines.
Methods: The study was conducted between 2007 and 2014 in two informal urban settlements in Nairobi. A total
of 3856 children, aged 12–23 months and having a vaccination card seen were included in analysis. Vaccination
dates recorded from the cards seen were used to define full immunization coverage, timeliness and sequencing.
Proportions, medians and Kaplan-Meier curves were used to assess and describe the levels of full immunization
coverage, vaccination delays and sequencing.
Results: The findings indicate that 67 % of the children were fully immunized by 12 months of age. Missing
measles and third doses of polio and pentavalent vaccine were the main reason for not being fully immunized.
Delays were highest for third doses of polio and pentavalent and measles. About 22 % of fully immunized children
had vaccines in an out-of-sequence manner with 18 % not receiving pentavalent together with polio vaccine as
recommended.
Conclusions: Results show higher levels of missed opportunities and low coverage of routine childhood
vaccinations given at later ages. New strategies are needed to enable health care providers and parents/guardians
to work together to increase the levels of completion of all required vaccinations. In particular, more focus is
needed on vaccines given in multiple doses (polio, pentavalent and pneumococcal conjugate vaccines).
Keywords: Fully immunized child, Coverage, Vaccination delay, Vaccination sequence
Background
Inadequate immunization is recognized as a major pub-
lic health concern as it accounted for about 17 % of all
deaths globally in children under five in 2008, prevent-
able with immunization [1]. Achieving universal vaccin-
ation coverage for all is one of the global sustainable
development targets aimed at reducing childhood
mortality from preventable deaths [2]. Full vaccination
coverage has been the cornerstone of immunization pro-
grammes in many countries, and it is estimated to avert
an estimated two to three million deaths every year in
all age groups from diphtheria, tetanus, pertussis and
measles [3]. Immunization programmes have been very
successful in protecting children against specific infec-
tions. Poliomyelitis infections are on the verge of
complete eradication with infection cases being reported
in four countries: Afghanistan, Pakistan, Nigeria and
Somalia [4].
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Basic immunization covers all vaccines given at any
time within the first year of life and has been the focal
point in evaluating immunization programmes [1, 3].
According to the World Health Organization (WHO)
guidelines [5], a child is fully immunized with all basic
vaccinations if the child has received Bacillus Calmette-
Guerin (BCG) vaccine against tuberculosis at birth; three
doses each of polio and pentavalent (diphtheria-tetanus-
pertussis-hepatitis B (Hep), Haemophilus influenza type
B (Hib)) vaccines at 6, 10 and 14 weeks of age; and a
vaccination against measles at 9 months of age.
Pneumococcal conjugate vaccine (PCV) given in three
doses (6, 10 and 14 weeks) was introduced in Kenya
in February 2011 and included in the routine
immunization schedule [6].
Globally, full immunization coverage for children aged
12–23 months increased to 83 % [1, 7] in 2011. In
Kenya, full immunization coverage for children aged
12–23 months currently stands at 79 and 75 %, respect-
ively, when PCV is considered [8]. Only 2 % of the chil-
dren aged 12–23 months had not received any vaccines
[8] in 2014. However, it is also important to note that
this figure can hide the variability in vaccine coverage [1,
8, 9] within Kenya and especially in urban informal set-
tlements where the full vaccination coverage was only
44 % [10] in 2002, 58 % [11] in 2010 and 68.5 % in 2012
[12] compared to coverage in Nairobi of 73 % [13] in
2009 and 79 % in 2013 [8]. Full immunization coverage
in Nairobi informal settlements depended on back-
ground characteristics of the child, mother and the
household [8, 10, 12, 14]. Given the inadequate health
care services in Nairobi informal settlements [15, 16]
where 60–70 % of the Nairobi population resides [10,
12], identification of areas with low immunization
coverage and achieving high immunization coverage
in these areas become paramount for health interven-
tion [17, 18].
The timing of vaccine is important for effectiveness
and safety of the vaccine. Timely administration of vac-
cines has implications for the success of childhood
immunization programmes, and a timely start of
immunization is important in the first year of life as the
transplacental immunity declines rapidly [19]. In prac-
tice, although a few children might be vaccinated early,
many will be vaccinated late [20] which reduces the im-
pact of vaccine programmes on disease burden especially
in high-risk groups [21]. Vaccines given before 6 weeks
of age (excluding BCG and polio at birth) have shown
poor response and in some cases could be detrimental
to infants as they reduce the immune response of subse-
quent doses [22]. Similarly, there is need to observe the
minimum recommended age for different vaccines
which are normally based on the youngest age group at
risk for the specific infections where vaccine safety and
efficacy have been demonstrated. Therefore, giving doses
earlier than scheduled or given closer to each other may
lead to a less optimal immune response [22]. On the
other hand, when a child’s vaccine is delayed, the inter-
val between doses/vaccines is increased and the optimal
vaccine protection may not be attained [22]. Simultan-
eous vaccination (pentavalent, polio and PCV doses) in-
creases the chance that a child will be fully vaccinated
on time and hence improving age-specific vaccine cover-
age [23, 24]. Therefore, the out-of-sequencing, early or
delays of vaccines may affect child survival. Several
studies have documented various reasons causing de-
lays in the administration of vaccines and their im-
pact. A recent paper from a study in Nairobi informal
settlements reveals that low birth weight infants re-
ceive BCG immunization later than normal birth
weight infants [25]. Measles and BCG vaccines are
known to have beneficial non-specific effects (NSE)
when given on time while the DPT containing vac-
cines does not seem to [26–31].
Few studies have documented timeliness and sequen-
cing of routine vaccinations in sub-Saharan Africa. In a
study done in Ghana in 2010, 44 % of children aged 12–
23 months had their measles vaccine delayed [32]. In
Burkina Faso, approximately 40 % of children aged 12–
23 months had their polio and pentavalent doses delayed
[33]. In an earlier study in the same study area as the
current study, delays in measles vaccine (MV) were esti-
mated at 20 % among boys and 24 % among girls [34].
Immunization timeliness have been documented in sev-
eral studies [25, 34–38], but almost none have looked at
the levels of out-of-sequence. This gap forms the basis
of this paper, which documents the levels of full
immunization coverage both overall and by different fac-
tors of interest. The study also aims to document the
levels of early and delayed immunization. Overall levels
of out-of-sequencing of the routine vaccinations in two
informal settlements in Nairobi, Kenya, are documented
as well as by different factors of interest. A key strength
of this study over others is the use of a longitudinal
study design particularly to study timing and out-of-
sequencing of routine vaccinations in urban poor
settings.
Methods
Study setting
The study was carried out in two informal settlements
of Nairobi (Viwandani and Korogocho) between 2007
and 2014 in the Nairobi Urban Health and Demographic
Surveillance System (NUHDSS) ran by the African
Population and Health Research Center (APHRC). The
NUHDSS has been in operation since 2002 and had
about 81,129 registered inhabitants in approximately
31,977 households as of December 2012. The two
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informal settlements are densely populated with high
unemployment, crime, poor sanitation and poorer health
indicators generally as compared to the whole of
Nairobi. There are notable differences between the two
settlements: Korogocho is more stable with less disparity
in terms of gender and age distribution as compared to
Viwandani which borders an industrial area and at-
tracts migrant workers with relatively high education
levels. The two communities are mainly served by
private health facilities and two public health facilities
located outside the area. Details of the study areas
and operations of the NUHDSS have been published
elsewhere [15, 16, 39].
Study population
This study used data from a longitudinal maternal and
child health project implemented in Korogocho and
Viwandani whose details have been published elsewhere
[25]. The study included all children born in the study
area from September 2006 to December 2013. For pur-
pose of this study, we used data for children aged 12–
23 months. All children without a vaccination card were
excluded from the analysis. Figure 1 gives a diagram-
matic description of how the final sample was derived.
Study design
The study involved a longitudinal observational study
design to study the outcomes. The mother-child pairs in
the study were followed up every 4 months collecting in-
formation on the immunization status of the child at
each visit using structured questionnaires administered
by trained research assistants. We use vaccination data
collected from the time of recruitment for children aged
12–23 months.
Variables
This study assessed the levels and patterns of the routine
vaccination uptake in the study area. The primary out-
come variable of interest was fully immunized children
(FIC) coverage. The secondary outcomes of interest were
vaccination sequencing and timing of immunization
(early or delayed). FIC was defined as a child who
has received all the recommended basic vaccines by
12 months of age, i.e. BCG at birth, polio doses at 6
(42), 10 (70) and 14 (98) weeks (days) of age; penta-
valent doses at 6 (42), 10 (70) and 14 (98) weeks
(days) of age; and measles dose at 9 (274) months
(days) of age. Early vaccination was defined as any
vaccine given more than 4 days before recommended
age for each vaccine/dose [40, 41]. In addition, for
the measles vaccine, we assessed doses given more
than 2 weeks before the recommended age. A vaccine
is delayed if it is given more than 2 weeks after the
recommended age for BCG, polio, pentavalent and
PCV doses and more than a month for measles [42,
43]. Out-of-sequence (OS) was defined as either re-
ceiving (i) BCG after or with any of the other routine
vaccines, (ii) any pentavalent vaccine dose with or
after the MV or (iii) receiving respective pentavalent
and polio doses at different days [44, 45]. A fully im-
munized child in out-of-sequence (FIC-OS) was de-
fined as a child who is FIC and had at least one
vaccine given in out-of-sequence.
Maternal education (none, primary and secondary or
higher), ethnicity (Kikuyu, Luhya, Luo, Kamba or other),
sex of child and delivery place (health facility or not),
wealth status calculated using principal component
analysis (lower, middle or upper) and study location
(Korogocho or Viwandani) were included in the analysis.
FIC coverage was also assessed by year of visit with
10,035-Number of children recruited into the study between 2006 and 2014
46,547-Total number of visits during the whole period of the study
9,980 (99%) - Number of children with at least one visit 
where a vaccination card was seen by the interviewer
55 (1%) - Number of children who
vaccination card was never seen by the
interviewer
8,484 (85%) - Number of children with visits where a card was 
seen
41,594-Total number of visits with vaccination card seen
1,496 (15%) - Number of children
with visits where card was not seen
4,821-Number of interview visits
where vaccination card was not  seen
Final sample for analysis
3,856 (45%) - Children aged 12-23 months at the time of
interview and a vaccination card seen
Fig. 1 Derivation of the sample of children included in the study
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coverage in a given year reflecting vaccines given be-
tween 1 and 2 years earlier.
Data analysis
All children aged 12–23 months of age and a vaccination
card seen were included in the analysis. For children
with more than one interview visit, the earliest visit was
picked for the analysis. Proportions were used to assess
the levels of FIC coverage, out-of-sequence, early and
delayed vaccination. The Kaplan-Meier method was used
to calculate vaccination coverage curves, and the log
rank test was used to compare vaccination coverage curves
by FIC status. Median age at vaccination was used to assess
the levels of vaccination delays. Chi-square test of inde-
pendence was used to test independence between FIC
coverage and levels of out-of-sequence by the different
background characteristics while median test was used to
test equality of medians. All tests were conducted at a 5 %
level of significance. Stata software version 13.1 was used
for all data management and analysis.
Ethics, consent and permissions
The study was approved by the Kenya Medical Research
Institute (KEMRI) ethical review committee. The re-
search assistants were trained on research ethics and ob-
tained both written and verbal informed consent from
all the study respondents. The NUHDSS, on which the
study was nested, also received ethical approval.
Results
Descriptive
The descriptive results are summarized in Table 1. A
total of 3856 out of 10,035 (38 %) children met the in-
clusion criteria and were included in the study. Sixty-
two percent of the children were excluded due to lack of
an interview visit where a vaccination card was seen be-
tween 12 and 23 months of age. The sample had slightly
more males (50.5 %) compared to females (49.5 %). Most
of the children were delivered in a health facility
(83.4 %), with majority of the mothers aged below
25 years (56.2 %) and having primary level of education
(70 %). Majority of the mother-child pairs attended post-
natal care (92.4 %). The last column in Table 1 summa-
rizes FIC coverage by different background factors for
children aged 12–23 months. There was no significant
difference in FIC coverage between a male and female
child. Significantly higher FIC coverage was observed
among mothers from Viwandani area (74.1 %) compared
to Korogocho (58.1 %) and among mothers who
attended postnatal care (67.7 %) compared to mothers
who did not attend postnatal care (53.3 %). FIC coverage
varied significantly by maternal education level, parity
and household wealth status.
Vaccination coverage
Table 2 summarizes coverage for each antigen and over-
all FIC coverage by year of visit. Overall FIC coverage
was estimated at 66.6 % in the study area. FIC coverage
was estimated at 66, 69, 72, 70, 68, 61 and 55 % for the
years 2008, 2009, 2010, 2011, 2012, 2013 and 2014, re-
spectively. BCG, oral polio vaccine (OPV) 1 and 2 and
pentavalent 1 and 2 coverage were estimated at 97.1,
99.1, 96.6, 99 and 96.6 %, respectively. Lower coverages
were observed for OPV 3 (82–88 %), pentavalent 3
(85–89 %) and measles (68–87 %). The coverage of
PCV doses were low in 2011, the year PCV was
rolled out in Kenya. Vaccination coverage of each
antigen by different background characteristics are
given in Additional file 1: Table S1.
Median age of vaccination
The median age and interquartile range (IQR) of
each antigen are summarized for non-FIC children
(Additional file 2: Table S2a) and FIC children
(Additional file 2: Table S2b) by background charac-
teristics. The median age for BCG was estimated at
6 days (IQR 1–14) for FIC and 8 days (IQR 2–17)
for non-FIC children. Median age for BCG varied
significantly by postnatal care attendance, delivery
place, parity and ethnicity among FIC children and
delivery place and ethnicity among non-FIC children.
Median age for the third dose of pentavalent was es-
timated at 107 (102–114) and 110 (103–126) days
for non-FIC and FIC children, respectively. The me-
dian age for the third dose of polio was estimated at
111 (104–129) days for non-FIC and 107 (102–116)
days for FIC children with significant differences ob-
served by maternal level of education, delivery place,
parity, ethnicity, wealth status and location for both
FIC and non-FIC children. Median age for the MV
was estimated at 282 (275–294) days among FIC
children and 290 (277–323) days for non-FIC chil-
dren with significant differences observed by child’s
gender for FIC children and by postnatal care,
mother’s age, parity, ethnicity, wealth status and lo-
cation for non-FIC children.
The coverage curves are shown in Fig. 2 for the whole
period and for each year’s visit in the additional file
(Additional file 3: Figure S1a and S1b). The curves for
each vaccine by definition end at 100 % for FIC children.
Vaccination timing among FIC are remarkable especially
for the polio and pentavalent doses which are almost up-
right apart from a few children who received them a bit
later. The MV and BCG coverage curves appear less up-
right. The FIC coverage curves for the OPV doses im-
proved over the years. The coverage curves among the
non-FIC children do not reach 100 % and are less up-
right compared to FIC children which shows that more
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non-FIC children have their vaccines delayed compared
to FIC. Results from log rank tests showed significant
differences in Kaplan-Meier curves between third
doses of polio and pentavalent (P value 0.004) and
non-significant differences between the first doses (P
values = 0.242) and second doses (P value = 0.054) of
polio and pentavalent vaccines in all children, respect-
ively. Significant differences (P value <0.001) in
Kaplan-Meier curves of each antigen by FIC status
were observed from log rank tests. Additional file 4:
Table S3 shows children are receiving their vaccines
earlier than recommended ages: more than 4 days for
OPV 1 (3.3 %) and pentavalent 1 (2.7 %) and MV
(8.4 %). Five percent of the children received MV
more than 14 days before the appropriate age. The
proportion of early immunization is high among the
non-FIC compared to FIC children for pentavalent
doses (P values, 0.005, 0.029 and 0.001 for first, sec-
ond and third doses, respectively) and the first polio
dose (P value = 0.010).
Table 1 Sample characteristics and FIC coverage at 12 months of age among children aged 12–23 months
No. Percent % FIC Overall P value
Childs gender Male 1925 50.5 66.0 0.391
Female 1889 49.5 67.3
Postnatal care No 289 7.6 53.3 <0.001
Yes 3511 92.4 67.7
Mother’s age group 11–20 907 24.6 64.5 0.254
21–24 1166 31.6 67.9
25–29 928 25.2 68.4
30–55 688 18.7 66.1
Mother’s education level <Primary 94 2.6 57.4 <0.001
Primary 2539 70 64.9
Secondary+ 995 27.4 72.7
Place of delivery Health facility 3172 83.4 67.5 0.017
Not health facility 630 16.6 62.5
Parity One 1231 32.4 71.9 <0.001
Two 1171 30.8 66.4
Three and above 1399 36.8 62.2
Ethnicity Kikuyu 952 25.8 70.6 <0.001
Luhya 696 18.9 62.9
Luo 603 16.3 58.4
Kamba 829 22.5 73.9
Other 611 16.6 63.5
Wealth status Lower 1224 33.4 61.1 <0.001
Middle 1216 33.2 70.2
Upper 1221 33.4 69.6
Study site Korogocho 1779 46.6 58.1 <0.001
Viwandani 2035 53.4 74.1
Year of visit 2008 921 24.1 65.6 <0.001
2009 303 7.9 68.6
2010 413 10.8 72.4
2011 603 15.8 69.5
2012 941 24.7 67.7
2013 440 11.5 60.7
2014 193 5.1 55.4
N 3814
Proportions significantly different at 5 % level of significance are highlighted in italics
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Vaccine sequence
Table 3 summarizes levels of FIC-OS. Overall, 21.7 % of
FIC children were FIC-OS. The levels of FIC-OS were
significantly higher among mothers not attending post-
natal care (29.2 %), those that did not deliver at a health
facility (31.0 %) and those from the Korogocho settle-
ment area (30.5 %) and also differed significantly by eth-
nicity group and household wealth status. The main
cause of being FIC-OS was not receiving pentavalent
and polio doses together (18.2 %).
Table 2 Immunization coverage at 12 months of age among children aged 12–23 months by year of visit
Year of visit
2008 2009 2010 2011 2012 2013 2014 2008–2014
% (#) % (#) % (#) % (#) % (#) % (#) % (#) % (#)
BCG 98.4 (906) 97.7 (296) 96.9 (400) 96.8 (584) 96.3 (906) 96.6 (425) 97.4 (188) 97.1 (3705)
OPV 0 77.0 (709) 83.8 (254) 83.5 (345) 81.1 (489) 84.6 (796) 81.4 (358) 25.9 (050) 78.7 (3001)
OPV 1 99.3 (915) 99.0 (300) 100 (413) 98.3 (593) 99.0 (932) 99.5 (438) 96.9 (187) 99.1 (3778)
OPV 2 97.4 (897) 97.0 (294) 97.1 (401) 95.0 (573) 96.5 (908) 96.8 (426) 95.9 (185) 96.6 (3684)
OPV 3 82.5 (760) 86.1 (261) 87.9 (363) 84.1 (507) 88.1 (829) 88.4 (389) 84.5 (163) 85.8 (3272)
Penta 1 99.3 (915) 98.7 (299) 100 (413) 98.7 (595) 99.0 (932) 99.3 (437) 96.4 (186) 99.0 (3777)
Penta 2 97.1 (894) 96.7 (293) 97.6 (403) 96.5 (582) 96.2 (905) 96.1 (423) 94.8 (183) 96.6 (3683)
Penta 3 86.6 (798) 87.5 (265) 88.9 (367) 88.6 (534) 86.0 (809) 88.2 (388) 85.5 (165) 87.2 (3326)
PCV 1 61.4 (248) 90.6 (853) 97.7 (430) 93.3 (180) 86.5 (1711)
PCV 2 45.3 (183) 83.2 (783) 94.1 (414) 91.2 (176) 78.7 (1556)
PCV 3 31.4 (127) 70.1 (660) 80.0 (352) 79.3 (153) 65.3 (1292)
Measles 81.2 (748) 82.8 (251) 86.7 (358) 85.7 (517) 81.6 (768) 73.0 (321) 68.4 (132) 81.1 (3095)
FIC 8 65.6 (604) 68.6 (208) 72.4 (299) 69.5 (419) 67.7 (637) 60.7 (267) 55.4 (107) 66.6 (2541)
N 921 303 413 603 941 440 193 3814
P
ro
po
rt
io
n 
of
 c
hi
ld
re
n 
va
cc
in
at
ed
 (
%
)
0
25
50
75
100
0 6w 10w 14w 6m 9m 12m
Age
FIC
BCG Measles
0
25
50
75
100
0 6w 10w 14w 6m 9m 12m
Age
NON FIC
oiloPPentavalent
Fig. 2 Vaccine coverage curves by 12 months among children aged 12–23 months
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Table 4 summarizes reasons for a child not being FIC
in the study area. Approximately 60 and 17 % of chil-
dren who were not FIC were missing only one or two
vaccines, respectively. The main vaccines missing were
OPV 3 (42 %), MV (47 %) and pentavalent 3 (38 %). The
above-mentioned reasons are consistently observed in
all years where data was available (see Additional file 2:
Figure S1a and S1b)
Discussion
This study looks at the levels of coverage of fully
immunized children (FIC) by 12 months, timing of
Table 3 Proportion of children receiving vaccination in out-of-sequence (FIC-OS) by 12 months of age among children aged
12–23 months by different background factors
Late BCG (%) Pentas<>OPVs (%) Penta>=MV (%) FIC-OS (%) N Overall P value
Overall 4.0 18.2 0.8 21.7 2541 –
Sex
Male 4.5 17.5 0.9 21.3 1270 0.646
Female 3.5 18.9 0.8 22.1 1271
Postnatal
No PN 6.5 24.0 0.6 29.2 154 0.021
PN 3.9 17.7 0.8 21.2 2378
Mother’s age group
11–20 4.3 20.2 0.9 24.1 585 0.185
21–24 4.3 16.5 0.8 20.3 792
25–29 3.0 17.5 0.8 20.0 635
30–55 4.0 19.3 0.7 22.6 455
Education
<Primary 1.9 25.9 0.0 25.9 54 0.080
Primary 4.0 18.7 0.9 22.2 1647
Secondary+ 3.6 15.2 0.4 18.5 723
Delivery place
Health facility 2.5 17.7 0.6 20.0 2140
Non-HF 12.2 20.3 2.0 31.0 394 <0.001
Parity
Parity1 4.1 18.0 0.2 21.5 885 0.543
Parity2 3.9 17.2 1.2 20.6 778
Parity3+ 4.1 19.1 1.1 22.9 870
Ethnicity
Kikuyu 2.7 20.1 0.0 22.2 672 0.001
Luhya 5.0 20.3 1.4 25.1 438
Luo 5.4 22.2 1.4 26.7 352
Kamba 3.8 14.4 0.7 17.9 613
Other 3.6 14.7 1.0 17.5 388
Wealth status
Lower 4.3 25.4 1.2 29.0 748 <0.001
Middle 3.5 17.7 0.5 20.5 854
Upper 4.2 12.6 0.8 16.7 850
Study site
Korogocho 4.4 26.9 1.1 30.5 1033
Viwandani 3.8 12.2 0.7 15.7 1508 <0.001
Proportions significantly different at 5 % level of significance are highlighted in italics
Late BCG BCG given together or after any pentavalent or measles, Pentas<>OPVs corresponding pentavalent and polio not given together, Penta>=MV
pentavalent given together or after measles, FIC-OS fully immunized child by 12 months with either late BCG, Pentas<>OPVs or Penta>=MV
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vaccinations (early and delays) and sequencing of the
routine childhood vaccination in children aged 12–
23 months in urban informal settlement in Nairobi,
Kenya. FIC coverage was estimated at 66.6 %. Individual
antigen coverage were above 90 % apart from MV, OPV
3 and pentavalent 3. Overall FIC coverage was shown to
depend on postnatal care attendance, education, parity,
ethnicity, household wealth status and location. The me-
dian age of the different vaccines revealed significant
delay in immunization among the non-FIC children
compared to FIC children. Proportion of fully immu-
nized children in out-of-sequence (FIC-OS) was esti-
mated at 22 %. FIC-OS differed significantly by postnatal
care attendance, delivery place, ethnicity, household
wealth status and location. The study highlights main
reasons for not being FIC and identifies levels and
sources of FIC-OS.
The overall FIC coverage in this study was higher
compared to 44 % in a previous study conducted in ap-
proximately all informal settlements in Nairobi [10] in
2002. The estimates are similar to (68 %) results ob-
tained from a cross-sectional study targeting approxi-
mately all informal settlements in Nairobi [14]
conducted in 2012. The FIC coverage in this study still
lags behind Nairobi (81 %) and national estimates (79 %)
[46]. The increase in FIC coverage (57–68 %) in the
study area may be attributed to efforts made by the min-
istry of health and other stakeholders to improve the up-
take of health services and awareness from interventions
conducted in the study area, even though more needs to
be done to reduce the gap existing between informal
settlements and other parts of Nairobi. Increases in
immunization coverage have been reported in other
low- and middle-income countries over the years [7, 47].
Our results show FIC coverage differed by different
background characteristics. FIC coverage was high
among mothers who attended postnatal care, and this is
expected as their children have more chances of getting
the vaccines than those who do not make any follow-up
contact with a health centre after delivery. FIC coverage
was higher among children of mothers with high educa-
tion level, resonating with other studies [11, 13, 14, 48].
Mothers with lower parity had higher coverage com-
pared to mothers with higher parity, which has been
found in other studies [11, 49]. The more children a
mother has the more constraints on the little resources
available especially in informal settlements where levels
of poverty are high and affect health care utilization
[20]. Ethnicity also played a role in determining FIC
coverage. FIC coverage was higher among Kamba and
Kikuyu ethnic groups compared to other ethnic groups.
Similar results were found in other studies done in
Table 4 Proportion of non-FIC children with missing vaccines by number and type of vaccines among children aged 12–23 months
2008 2009 2010 2011 2012 2013 2014 Total
% % % % % % % %
Number of vaccine missing
0 (FIC after 12 months) 6.9 6.3 6.1 7.6 7.2 3.5 5.8 6.4
1 58.4 62.1 59.6 55.4 56.9 71.1 70.9 60.6
2 18.0 16.8 19.3 18.5 19.7 11.6 9.3 17.0
3 9.8 4.2 7.9 8.7 6.9 4.6 4.7 7.3
4 4.1 4.2 3.5 3.8 4.3 5.2 2.3 4.1
5 1.9 4.2 2.6 3.3 3.3 2.9 2.3 2.8
6 0.6 0.0 0.9 0.5 0.7 0.0 0.0 0.5
7 0.3 2.1 0.0 2.2 0.7 0.6 4.7 1.1
8 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.2
Vaccine missing by type
BCG 4.4 6.3 11.4 9.2 10.9 8.7 2.3 7.9
OPV 1 1.6 2.1 0.0 4.3 1.6 1.2 4.7 2.0
OPV 2 7.3 8.4 10.5 15.2 9.5 8.1 5.8 9.3
OPV 3 50.5 43.2 43.9 51.1 35.5 29.5 32.6 41.8
Penta 1 1.9 4.2 0.0 3.8 3.0 1.7 8.1 2.8
Penta 2 8.5 10.5 8.8 10.9 11.8 9.8 11.6 10.2
Penta 3 38.8 40.0 40.4 37.0 43.4 30.1 32.6 38.3
MV 42.6 46.3 39.5 37.0 46.1 63.0 59.3 46.5
N 317 95 114 184 304 173 86 1273
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Kenya, and this has been linked to cultural differences in
addition to education and income disparities among the
different ethnicities [11, 14, 34]. FIC coverage was higher
among children from households with higher wealth sta-
tus. This has been documented in other studies done in
Kenya [8, 11, 13, 14] and India [48] where health out-
comes are better off among the wealthier in the commu-
nity compared to the less wealthy households. FIC
coverage was found to be higher in Viwandani compared
to Korogocho study area in line with earlier studies [11].
Viwandani area is next to an industrial area, and resi-
dents here are better off than Korogocho residents.
This study showed higher coverage for vaccines given
during an infant’s early part of life and lower for vaccines
given later in life specifically OPV 3, pentavalent 3, PCV
3 and MV. This resonates well with previous findings in
the study area [11, 13] and other studies conducted in
Burkina Faso, Nigeria and South Africa [33, 36, 37]. The
issue of not completing recommended doses of a vaccine
is a concern. A child is protected optimally from specific
infections if the child received all the three doses. When
a dose is skipped, delayed or missed altogether, the child
becomes vulnerable from the specific infection and also
‘herd’ immunity is compromised [50]. The low coverage
of MV poses similar concerns. Studies have shown MV
and BCG vaccines to be having non-specific beneficial
effects on child survival [26–28, 31, 51–58]. The high
number of infants missing out on MV vaccines could be
missing out on these benefits.
The study showed an initial increase of FIC coverage
between 2008 and 2010 followed by a decrease between
2011 and 2014. Further investigation is needed in the
study area to understand this scenario. In general, there
has been an increase in FIC coverage from the study
area compared to similar studies conducted in the
current area [10, 11]. Another cross-sectional study con-
ducted in approximately all informal settlements in
Nairobi in 2012 showed equivalent FIC coverage [14].
Though this study provides evidence of increase in FIC
coverage over the last decade [10], the coverage is still
lower in poor urban settlements as compared to
estimates from other urban areas and Nairobi in particu-
lar [8, 13]. Children missing MV, OPV 3 and pentavalent
3 vaccines were identified by the study as the main
reasons of not being fully immunized. Similar observa-
tions were made by other studies conducted in other set-
tings [36, 59].
A substantial number of children started their routine
immunization much earlier than the recommended age.
Similar result has been reported elsewhere in Nigeria,
Mozambique and Guinea [37, 60]. Studies have shown
that vaccines given more than 4 days earlier than the
recommended age may not be optimally effective [24]
and one may need to re-vaccinate.
The study established substantial levels of delays in
BCG, OPV 3, pentavalent 3 and measles vaccine cover-
age. This is consistent with other studies in sub-Saharan
Africa [37]. The study showed most of the specific vac-
cines delays were associated with postnatal attendance,
ethnicity, education level and delivery place, social eco-
nomic status and location of the household. These same
factors were identified as being associated with being
FIC by 12 months of age. Similar results have been
found in other studies as determinants of vaccine delays
[32, 33, 45, 61, 62].
This study provides evidence of children receiving vac-
cines in a different sequence than recommended. The
main contributor of being FIC-OS was identified as not
receiving the pentavalent and corresponding polio dose
together. This highlights levels of missed opportunities
in immunization programmes as the child had contact
with a health care person and was only given one vac-
cine instead of two. This may be occasioned by vaccine
stock-outs.
Overall, the study underscores the importance of a
child being fully immunized and getting the vaccines on
time and in the correct sequence. The existence of dis-
parities even among the underprivileged in these popula-
tion have implications that policymakers need to be
aware of. The results highlight the simple measures
which can be taken to improve on coverage, timing and
sequencing of the vaccines. This means that the lower
immunization coverage and age-specific vaccination
coverage can easily be improved by targeting the disad-
vantaged groups. Special focus is needed on the uptake
of all the three doses for polio, pentavalent and PCV
vaccines, at the same time making sure a child is given
all the doses that are supposed to be given at the same
day when there is contact with a health centre. Ensuring
that parents/guardian know the importance of the chil-
dren receiving all the three doses of the key vaccination
will improve not only coverage but also making sure the
child has received the vaccine at the right time.
This study was conducted in an urban informal settle-
ment, and therefore, the estimated coverages, levels of
delays and out of sequence may only represent similar
populations. A major limitation of this study was that
we did not see a vaccination card for a large number
(62 %) of those recruited during the visits between 12
and 23 months of age and hence they were excluded
from the analysis. However, on the positive side, the ex-
clusion eliminated the possibility of introducing recall
and survival bias in the analysis. Despite the exclusion,
the analysis still included a reasonable sample size. How-
ever, excluding children without an observed vaccination
card may impact the internal validity of the results
within the target population as vaccine coverage among
these children may differ in substantial ways from
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children with an observed vaccination card. The major
strength of the study was the longitudinal nature of the
study which gives an opportunity of visiting the re-
spondent several times. This helps in getting better esti-
mate and trend data compared to cross-sectional studies
which only give a snapshot of vaccination coverage at a
given time.
Conclusions
The study reveals high levels of missed opportunities in
the administration of routine childhood vaccinations. A
substantial number of children were not fully immu-
nized by the end of their first year of life; even when
they are fully immunized, a sizeable number received
their vaccines inappropriately, either early, delayed or in
a different sequence from the recommended schedule.
New strategies are needed to enable health care pro-
viders and parents/guardians to work together to in-
crease the levels of completion of all required vaccines.
In particular, more focus is needed on measles and vac-
cines given in multiple doses (polio, pentavalent and
pneumococcal conjugate vaccine) to make sure children
receive all the three doses. This study contributes to the
documentation of patterns of routine immunization up-
take in urban poor settlements in Kenya and similar
settings.
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